{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:18:01Z","timestamp":1745554681223,"version":"3.40.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science and Technology Program of Shenzhen","award":["JCYJ20220530155616038","JCYJ20220530155616038","JCYJ20220530155616038","JCYJ20220530155616038"],"award-info":[{"award-number":["JCYJ20220530155616038","JCYJ20220530155616038","JCYJ20220530155616038","JCYJ20220530155616038"]}]},{"name":"Guang Dong Basic and Applied Basic Research Foundation","award":["2022A1515111121","2022A1515111121","2022A1515111121","2022A1515111121"],"award-info":[{"award-number":["2022A1515111121","2022A1515111121","2022A1515111121","2022A1515111121"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Philadelphia chromosome-positive (Ph<jats:sup>+<\/jats:sup>) acute lymphoblastic leukaemia (ALL) in childhood is associated with dismal outcomes, in large part due to challenges in diagnosis and monitoring therapeutic efficacy. Recent studies suggest that circular RNAs (circRNAs) are potential diagnostic and prognostic biomarkers for various tumours. to indicate the potential role of circRNAs in identifying or serving as novel targets for treatments. Here, we analysed CircRNA expression profiles in samples from three Ph<jats:sup>+<\/jats:sup> ALL patients at diagnosis (CK1 group), on day 19 after treatment (T1 group) and in first complete remission (day 46 after treatment, T2 group), as well as one Ph<jats:sup>\u2212<\/jats:sup> ALL patient at diagnosis (CK2 group). A total of 922 differentially expressed circRNAs (DECs) potentially associated with RNA degradation, microRNAs in cancer, propanoate metabolism and ubiquitin-mediated proteolysis were found (626 upregulated and 296 downregulated) between the CK1 and CK2 groups. In addition, we identified 224 DECs (129 upregulated and 95 downregulated) between the CK1 and T1 groups and 225 DECs (136 upregulated and 89 downregulated) between the CK1 and T2 groups, including 136 for which their expression was upregulated and 89 for which their expression was downregulated. The levels of hsa_circ_0012152 and hsa_circ_0009024 were significantly increased in Ph<jats:sup>+<\/jats:sup> ALL patients, the changes in the levels of these circRNAs were confirmed by qRT\u2012PCR, indicating their potential as diagnostic biomarkers. Most upregulated DECs underwent N6-methyladenosine (m6A) modification noting the specific roles that are now better understood based on the circRNAs and DECs identified, and ideally suggesting how the findings could impact the diagnosis and treatment of Ph<jats:sup>+<\/jats:sup> ALL The findings of this study increase our understanding of the roles of m6A-modified circRNAs in the pathogenesis of Ph<jats:sup>+<\/jats:sup> ALL.<\/jats:p>","DOI":"10.1038\/s41598-025-97345-0","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T09:01:33Z","timestamp":1745485293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential expression and functional analysis of circular RNAs and m6A modifications in children with Philadelphia chromosome-positive acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"15","author":[{"given":"Lichun","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuiqin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maochuan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guichi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Fen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei-Qiu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"97345_CR1","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1200\/JCO.23.01286","volume":"41","author":"R Pieters","year":"2023","unstructured":"Pieters, R., Mullighan, C. G. & Hunger, S. P. Advancing diagnostics and therapy to reach universal cure in childhood ALL. J. Clin. Oncol. 41, 5579\u20135591 (2023).","journal-title":"J. Clin. Oncol."},{"key":"97345_CR2","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","volume":"54","author":"SW Brady","year":"2022","unstructured":"Brady, S. W. et al. The genomic landscape of pediatric acute lymphoblastic leukemia. Nat. Genet. 54, 1376\u20131389 (2022).","journal-title":"Nat. Genet."},{"key":"97345_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/cncr.33321","volume":"127","author":"W Stock","year":"2021","unstructured":"Stock, W. et al. Efficacy of inotuzumab Ozogamicin in patients with Philadelphia chromosome-positive relapsed\/refractory acute lymphoblastic leukemia. Cancer 127, 905\u2013913 (2021).","journal-title":"Cancer"},{"key":"97345_CR4","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","volume":"105","author":"H Inaba","year":"2020","unstructured":"Inaba, H. & Mullighan, C. G. Pediatric acute lymphoblastic leukemia. Haematologica 105, 2524\u20132539 (2020).","journal-title":"Haematologica"},{"key":"97345_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak, S. et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333\u2013338 (2013).","journal-title":"Nature"},{"key":"97345_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-022-01620-x","volume":"21","author":"H Lin","year":"2022","unstructured":"Lin, H., Wang, Y., Wang, P., Long, F. & Wang, T. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. Mol. Cancer. 21, 148 (2022).","journal-title":"Mol. Cancer"},{"key":"97345_CR7","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3389\/fonc.2019.01108","volume":"9","author":"M Jamal","year":"2019","unstructured":"Jamal, M. et al. Recent progress on circular RNA research in acute myeloid leukemia. Front. Oncol. 9, 1108 (2019).","journal-title":"Front. Oncol."},{"key":"97345_CR8","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.ccell.2023.05.002","volume":"41","author":"VM Conn","year":"2023","unstructured":"Conn, V. M. et al. Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia. Cancer Cell. 41, 1309\u20131326e10 (2023).","journal-title":"Cancer Cell."},{"key":"97345_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s13577-021-00504-4","volume":"34","author":"Y Hou","year":"2021","unstructured":"Hou, Y. et al. Circular RNA CircRNA_0000094 sponges microRNA-223-3p and up-regulate F-box and WD repeat domain containing 7 to restrain T cell acute lymphoblastic leukemia progression. Hum. Cell. 34, 977\u2013989 (2021).","journal-title":"Hum. Cell."},{"key":"97345_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000). [PMID:10592173].","journal-title":"Nucleic Acids Res."},{"key":"97345_CR11","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"97345_CR12","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"97345_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2217\/epi-2019-0153","volume":"12","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Circular RNA expression profile and m6A modification analysis in poorly differentiated adenocarcinoma of the stomach. Epigenomics 12, 1027\u20131040 (2020).","journal-title":"Epigenomics"},{"key":"97345_CR14","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1093\/nar\/gkw104","volume":"44","author":"Y Zhou","year":"2016","unstructured":"Zhou, Y., Zeng, P., Li, Y. H., Zhang, Z. & Cui, Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 44, e91 (2016).","journal-title":"Nucleic Acids Res."},{"key":"97345_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/onc.2017.361","volume":"37","author":"LS Kristensen","year":"2018","unstructured":"Kristensen, L. S., Hansen, T. B., Ven\u00f8, M. T. & Kjems, J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene 37, 555\u2013565 (2018).","journal-title":"Oncogene"},{"key":"97345_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cell.2016.03.020","volume":"165","author":"J Guarnerio","year":"2016","unstructured":"Guarnerio, J. et al. Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations. Cell 165, 289\u2013302 (2016).","journal-title":"Cell"},{"key":"97345_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-0609.2009.01392.x","volume":"84","author":"D Caramazza","year":"2010","unstructured":"Caramazza, D. et al. Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype\u2013phenotype associations. Eur. J. Haematol. 84, 191\u2013200 (2010).","journal-title":"Eur. J. Haematol."},{"key":"97345_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mrgentox.2015.07.012","volume":"793","author":"N Brown","year":"2015","unstructured":"Brown, N., Finnon, R., Manning, G., Bouffler, S. & Badie, C. Influence of radiation quality on mouse chromosome 2 deletions in radiation-induced acute myeloid leukaemia. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 793, 48\u201354 (2015).","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"97345_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/sj.leu.2401622","volume":"14","author":"R Lindquist","year":"2000","unstructured":"Lindquist, R., Forsblom, A. M., \u00d6st, \u00c5. & Gahrton, G. Mutagen exposures and chromosome 3 aberrations in acute myelocytic leukemia. Leukemia 14, 112\u2013118 (2000).","journal-title":"Leukemia"},{"key":"97345_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cancergen.2015.03.013","volume":"208","author":"D Liu","year":"2015","unstructured":"Liu, D. et al. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities. Cancer Genet. 208, 333\u2013340 (2015).","journal-title":"Cancer Genet."},{"key":"97345_CR21","doi-asserted-by":"publisher","first-page":"1010579","DOI":"10.3389\/fphar.2022.1010579","volume":"13","author":"M Zhou","year":"2022","unstructured":"Zhou, M., Gao, X., Zheng, X. & Luo, J. Functions and clinical significance of circular RNAs in acute myeloid leukemia. Front. Pharmacol. 13, 1010579 (2022).","journal-title":"Front. Pharmacol."},{"key":"97345_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-022-01508-w","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Insights into N6-methyladenosine and programmed cell death in cancer. Mol. Cancer. 21, 32 (2022).","journal-title":"Mol. Cancer"},{"key":"97345_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang, H., Weng, H. & Chen, J. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 37, 270\u2013288 (2020).","journal-title":"Cancer Cell."},{"key":"97345_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-020-01224-3","volume":"19","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circrnas. Mol. Cancer. 19, 105 (2020).","journal-title":"Mol. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97345-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97345-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97345-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T09:01:34Z","timestamp":1745485294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97345-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97345"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97345-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13976"}}